Quibim, a company developing imaging biomarkers for precision medicine that has created AI-based software to identify early-stage neurodegenerative diseases, has announced the launch of QP-Brain
A ceramic blanket being developed improve blood flow and speed up wound healing has shown potential as an innovative treatment for Parkinson's disease.
Almost 80 per cent of people return to work after traumatic spinal fracture or spinal cord injury (SCI), new research suggests.
More than a third of neurologists in the US believe Bruton’s tyrosine kinase (BTK) inhibitors have huge potential as a future treatment of multiple sclerosis (MS), according to findings from a recent Spherix Global Insights’ survey.
French biopharmaceutical company Axoltis Pharma has announced promising results from its phase 1b clinical trial evaluating NX210c - an innovative therapy for neurodegenerative diseases and traumas.
An Edinburgh med-tech company has received almost half a million pounds in UK Government funding to develop an assistive robotic glove for stroke patients.
Two leading standards bodies have launched a new group aimed at connecting global neuroscience and genomic data to speed up research
Professor Per Saris at the University of Helsinki said: "Our findings are significant, as the cause of Parkinson's disease has gone unknown despite attempts to identify it throughout the last two centuries"
The injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) has a long-lasting effect that appears to protect the brain from further damage, new research has found.
Rates of dementia are rising exponentially. By 2050, 153 million people are expected to be living with the condition worldwide. But a societal fear of the condition has produced a stigma that cannot easily be shaken off.
Dementia is among the public’s most feared conditions, second only to cancer. For many, a diagnosis signifies the end of their life. This fear, coupled with a lack of understanding of what it means to live with the condition, means patients are often pushed away and left feeling isolated.
Other Aspect Health Media Titles
Copyright © 2025 Aspect Health Media Ltd
